Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:LABS NYSE:MXF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABSMediPharm LabsC$0.08C$0.07C$0.06▼C$0.12C$31.56M0.295045290,591 shs468,484 shsMXFMexico Fund$18.86-1.7%$18.48$12.99▼$19.86$276.11M0.9556,170 shs19,583 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABSMediPharm Labs0.00%+7.14%0.00%+15.38%+7.14%MXFMexico Fund0.00%-1.01%+4.40%+8.55%+24.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABSMediPharm LabsC$0.08C$0.07C$0.06▼C$0.12C$31.56M0.295045290,591 shs468,484 shsMXFMexico Fund$18.86-1.7%$18.48$12.99▼$19.86$276.11M0.9556,170 shs19,583 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABSMediPharm Labs0.00%+7.14%0.00%+15.38%+7.14%MXFMexico Fund0.00%-1.01%+4.40%+8.55%+24.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABSMediPharm Labs 0.00N/AN/AN/AMXFMexico Fund 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABSMediPharm LabsC$44.45M0.71C$0.06 per share1.30C$0.11 per share0.68MXFMexico Fund-$34.30M-8.05N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABSMediPharm Labs-C$12.05M-C$0.02N/A∞N/A-30.56%-24.41%-7.17%N/AMXFMexico FundN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLABSMediPharm LabsN/AN/AN/AN/AN/AMXFMexico Fund$0.914.74%N/AN/AN/ALatest LABS, IHR, MXF, and PHP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/11/2025MXFMexico Fundquarterly$0.255.3%10/22/202510/22/202510/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLABSMediPharm Labs1.453.213.10MXFMexico FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABSMediPharm Labs0.34%MXFMexico FundN/AInsider OwnershipCompanyInsider OwnershipLABSMediPharm Labs4.45%MXFMexico Fund2.69%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABSMediPharm Labs130420.76 millionN/ANot OptionableMXFMexico FundN/A14.64 million14.25 millionNot OptionableLABS, IHR, MXF, and PHP HeadlinesRecent News About These CompaniesMexico Fund, Inc. (The) $MXF Shares Sold by Public Employees Retirement System of OhioSeptember 30, 2025 | marketbeat.comCuellar Maria Regina Garcia Purchases 724 Shares of Mexico Fund (NYSE:MXF) StockSeptember 20, 2025 | marketbeat.comMexico Fund, Inc. (The) Announces Quarterly Dividend of $0.25 (NYSE:MXF)September 14, 2025 | marketbeat.comTHE MEXICO FUND, INC. DECLARES DISTRIBUTIONSeptember 11, 2025 | prnewswire.comTrump extends Mexico's current tariffs for 90 daysJuly 31, 2025 | msn.comTHE MEXICO FUND, INC. PAYS DISTRIBUTIONJuly 30, 2025 | prnewswire.comTHE MEXICO FUND ACKNOWLEDGES SABA CAPITAL MANAGEMENT, L.P. INVESTMENT, REAFFIRMS COMMITMENT TO SHAREHOLDER VALUEJuly 28, 2025 | prnewswire.comMexico Closed Fund News (MXF) - Investing.comJuly 18, 2025 | investing.comMexico Fund: Still Not Very CompellingJuly 10, 2025 | seekingalpha.comUpcoming Dividend Run For MXF? - NasdaqJuly 8, 2025 | nasdaq.comTHE MEXICO FUND, INC. ISSUES ITS 2025 SEMI-ANNUAL REPORTJune 26, 2025 | prnewswire.comTHE MEXICO FUND, INC. DECLARES DISTRIBUTIONJune 23, 2025 | prnewswire.comInsider Buying: The Mexico Fund, Inc. (NYSE:MXF) Director Acquires 865 Shares of StockMay 21, 2025 | insidertrades.comTHE MEXICO FUND, INC. PAYS DISTRIBUTIONApril 30, 2025 | gurufocus.comTHE MEXICO FUND, INC. PAYS DISTRIBUTIONApril 30, 2025 | prnewswire.comMexico Expands Its Largest Port as It Bets on Global Trade Despite Trump's TariffsApril 25, 2025 | msn.comMexico Fund Inc Releases Monthly Summary ReportApril 7, 2025 | tipranks.comThe Mexico Fund, Inc. (NYSE:MXF) Director La Calle Luis De Acquires 6,000 SharesMarch 14, 2025 | insidertrades.comTHE MEXICO FUND, INC. DECLARES DISTRIBUTIONMarch 7, 2025 | gurufocus.comTHE MEXICO FUND, INC. ANNOUNCES RESULTS OF ITS ANNUAL MEETING OF STOCKHOLDERSMarch 7, 2025 | gurufocus.comTHE MEXICO FUND, INC. ANNOUNCES RESULTS OF ITS ANNUAL MEETING OF STOCKHOLDERSMarch 7, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025Meta Debuts Next-Gen AI Glasses—A Turning Point for Reality Labs?By Leo Miller | September 28, 2025LABS, IHR, MXF, and PHP Company DescriptionsMediPharm Labs TSE:LABSC$0.08 0.00 (0.00%) As of 02:41 PM EasternMediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.Mexico Fund NYSE:MXF$18.86 -0.32 (-1.64%) As of 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Mexico Fund, Inc. is a closed-ended equity mutual fund launched and managed by Impulsora del Fondo México, S.C. It primarily invests in public equity markets of Mexico. The fund seeks to invest its portfolio across diversified sectors. The Mexico Fund, Inc. was formed in June 01, 1981 and is domiciled in Maryland, United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Behind D-Wave's Massive Week (And Why Rivals Also Popped) Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback Alphabet: After Its Best Quarter in Decades, Is It Time to Buy? Best Stocks Under $15? 3 Low-Priced Picks With Upside After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught? Starbucks Stock Slumps; This Competitor Shows Strength Broadcom’s VMware Push Takes Aim at Microsoft, Google, & Amazon How Berkshire's OxyChem Buy Cements Its Long-Term Strength Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
